Akinetopsia: Causes and Treatment
Akinetopsia is primarily caused by damage to cortical area V5/MT (middle temporal visual area), most commonly from stroke, neurodegenerative disease, or medication toxicity, and treatment focuses on addressing the underlying etiology since the condition itself is largely therapy-resistant when due to structural lesions. 1, 2
Causes
Structural Neurological Conditions
- Stroke and vascular lesions are the most common causes, with bilateral lesions to V5/MT most often resulting in global akinetopsia and chronic symptoms 1
- Brain metastases can cause akinetopsia when they affect the middle temporal area of the visual cortex 3
- Neurodegenerative diseases represent another major structural cause 1, 2
- Arteriovenous malformations in the parietal lobe can lead to akinetopsia 4
Hemispheric Lateralization
- In right-handed individuals, the left area V5/MT is particularly susceptible to acute interference during experimental stimulation 1
- However, right-hemispheric lesions are more prevalent in clinical cases, suggesting the right V5/MT plays a more dominant role in motion perception 1
- Bilateral V5/MT lesions most frequently coincide with global akinetopsia and chronicity 1
Medication-Induced Causes
- Nefazodone toxicity (an antidepressant that blocks serotonin reuptake and antagonizes 5-HT2 receptors) can cause reversible akinetopsia characterized by visual trails and "freeze-frame" images 5
- Medication-induced cases typically resolve with dose reduction or discontinuation 5
Paroxysmal Causes
- Epileptic seizures can manifest as recurrent akinetopsia due to hyperexcitability of temporal and parietal cortices including area MT/V5 4
- These cases present with paroxysmal, recurrent symptoms rather than continuous impairment 4
Clinical Characteristics
Symptom Patterns
- 12% present with hemiakinetopsia (motion blindness in one visual hemifield) 1
- 50% show continuous or progressive symptoms 1
- 52% follow a chronic course 1
- Severity depends on surviving components of the visual motion network as a whole and the speed of moving objects 1
Treatment Approach
Primary Strategy: Treat the Underlying Cause
- For epileptic akinetopsia: Carbamazepine (200 mg/day) can completely suppress symptoms by controlling seizure activity 4
- For medication-induced cases: Reduce or eliminate the offending medication (e.g., nefazodone), which typically results in complete resolution 5
- For structural lesions (stroke, neurodegenerative disease, metastases): These cases tend to be therapy-resistant with poor prognosis for recovery 1
Rehabilitation Considerations
While the provided guidelines focus on hemianopia and general vision rehabilitation rather than akinetopsia specifically, the principles suggest:
- Compensatory scanning training may be considered for patients with visual field deficits, though evidence quality is low 6
- Occupational therapy can help patients adapt to visual limitations and modify tasks and environment to enhance daily activities 6
- Multidisciplinary rehabilitation is appropriate for acquired brain injury with visual deficits 6
Important Caveats
- No specific rehabilitation protocols exist for akinetopsia itself, unlike other visual field defects 1
- Prognosis depends heavily on etiology: reversible causes (medications, epilepsy) respond well to treatment, while organic lesions remain largely untreatable 1
- The condition is more heterogeneous phenomenologically, pathophysiologically, and etiologically than previously recognized 1